期刊文献+

在人恶性胶质瘤原代培养细胞甲酰化肽受体FPR的表达和功能意义

Expression of functional formylpeptide receptor FPR by primary human malignant glioma cells
下载PDF
导出
摘要 目的观测甲酰化肽受体(formylpeptidereceptor,FPR)在人恶性胶质瘤原代培养瘤细胞的表达和功能活性。方法组织块培养和胰酶消化法分离、培养人恶性胶质瘤细胞并进行鉴定,分别采用间接免疫荧光染色结合激光共聚焦扫描、台盼蓝排染实验结合细胞计数、酶联免疫夹心吸附分析(ELISA)等方法观测培养细胞FPR的表达和定位、FPR配体fMLF活化FPR后细胞增殖以及分泌血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)的变化。结果部分胶质瘤原代培养细胞可见FPR表达,主要呈线性荧光信号定位于细胞膜;FPR阳性细胞对fMLF的刺激具有反应性,表现为细胞增殖速率加快,VEGF分泌量显著增加。结论部分人恶性胶质瘤细胞存在功能性FPR表达,并可促进瘤细胞增殖和VEGF的产生,在胶质瘤发展及血管生成过程中可能起重要作用。 Objective To detect the expression of formylpeptide receptor FPR in primary human glioma cells and its functional activity when stimulated with the ligand fMLF. Methods Human glioma tissues were employed with or without digestion with trypsin for primary culture of glioma cells. By using indirect immunofluorescence and confocal laser scanning microscopy, the expression and localization of FPR in the primary glioma cells were detected. Meanwhile, the cell proliferation in vitro and the production of vascular endothelial growth factor (VEGF) by primary cultured cells after FPR activation with its ligand fMLF, were assessed by trypan blue exclusion assay and enzyme-linked immunosorbent assay (ELISA) , respectively. Results The primary human malignant glioma cells expressed FPR on the plasma membrane, presenting discontinuous linear fluorescence. After FPR activation by fMLF, the cell proliferation in vitro was promoted, and the VEGF level secreted by primary glioma cells was increased significantly. A significantly positive correlation was found between FPR expression and the production of VEGF. Conclusion FPR was selectively expressed by the primary malignant glioma cells, and FPR activation promoted cell proliferation and the production of angiogenic factor VEGF in vitro.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2006年第24期2440-2443,共4页 Journal of Third Military Medical University
关键词 胶质瘤 甲酰化肽受体 血管内皮生长因子 原代培养 血管生成因子 glioma formylpeptide receptor vascular endothelial growth factor primary culture angiogenesis factor
  • 相关文献

参考文献9

  • 1RABIE M J,HUET E,BOULAY F.Human mitochondria-derived Nformylated peptides are novel agonists equally active on FPR and FPRL1,while Listeria monocytogenes-derived peptides preferentially activate FPR[J].Eur J Immunol,2005,35(8):2486-2495.
  • 2SUN R,IRIBARREN P,ZHANG N,et al.Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor[J].J Immunol,2004,173(1):428-436.
  • 3LE Y,IRIBARREN P,ZHOU Y,et al.Silencing the formylpeptide receptor FPR by short-interfering RNA[J].Mol Pharmacol,2004,66(4):1022-1028.
  • 4FARR-JONES M A,PARNEY F,PETRUK K C.Improved technique for establishing short term human brain tumor cultures[J].J Neurooncol,1999,43(1):1-10.
  • 5陈剑鸿,卞修武,杨世昕,王吉民.大鼠胶质瘤细胞系C6趋化因子受体CXCR4和甲酰肽受体FPR的表达[J].第三军医大学学报,2005,27(17):1722-1724. 被引量:1
  • 6LE Y,SUN R,YING G,et al.The role of peptide receptors in microbial infection and inflammation[J].Curr Med Chem Anti-Infet Agents,2003,2 (1):83-93.
  • 7LE Y,MURPHY P M,WANG J M.Formyl-peptide receptors revisited[J].Trends Immunol,2002,23 (11):541-548.
  • 8ZHOU Y,BIAN X,LE Y,et al.Formylpeptide receptor FPR and the rapid growth of malignant human gliomas[J].J Natl Cancer Inst,2005,97 (11):823 -835.
  • 9BIAN X W,CHEN J H,JIANG X F,et al.angiogenesis as and immunopharmacologic target in inflammation and cancer[J].Int Immunopharmacol,2004,4(12):1537-1547.

二级参考文献11

  • 1Balkwill F. Chemokine biology in cancer[J]. Semin Immunol, 2003,15(1): 49-55.
  • 2Zhou Y, Larsen P H, Hao C, et al. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival [ J ]. J Biol Chem,2002, 277(51 ): 49481 -49487.
  • 3Hu J Y, Deng X, BIAN X W, et al. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma [ J]. Clin Cancer Res, 2005, 11(13) : 4658 -4665.
  • 4Zhou Y, Bian X W, Le Y, et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas [ J ]. J Natl Cancer Inst,2005, 97 ( 11 ) : 823 - 835.
  • 5Bian X W, Chen J H, Jiang X F, et al. Angiogenesis as an immunopharmacologic target in inflammation and cancer [ J ]. Int Immunopharmacol. 2004. 4( 12), 1537 - 1547.
  • 6Rutka J T, Murakami M, Dirks P B, et al. Role of glial filaments in cells and tumors of glial origin: a review[ J]. J Neurosurg, 1997, 87( 3 ) : 420 - 430.
  • 7Fu H, Dahlgren C, Bylund J. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy [ J ].Antimicrob Agents Chemother, 2003, 47 (8) : 2545 - 2550.
  • 8Le Bon B, Van Craynest N, Daoudi J M, et al. AMD3100 conjugates as components of targeted nonviral gene delivery systems : synthesis and in vitro transfection efficiency of CXCR4-expressing cells [J]. Bioconjug Chem, 2004, 15(2) : 413 -423.
  • 9Rubin J B, Kung A L, Klein R S, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors [J].Proc Natl Acad Sci U S A, 2003, 100(23) : 13513 -13518.
  • 10VanCompernolle S E, Clark K L, Rummel K A, et al. Expression and function of formyl peptide receptors on human fibroblast cells[J].J Immunol, 2003, 171 (4) : 2050 -2056.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部